Sign up for our newsletter: GZERO Daily

At Pfizer, equity is a core value that drives our people every single day. We launched An Accord for a Healthier World because all people deserve access to high-quality, safe, and effective healthcare solutions.

Learn how this bold initiative could impact you at Pfizer.com.

At Pfizer, equity is a core value that drives our people every single day. We launched An Accord for a Healthier World because all people deserve access to high-quality, safe, and effective healthcare solutions.

Learn how this bold initiative could impact you at Pfizer.com

All precious cargo needs a reliable vehicle to get it to its final destination.

Such is the case for messenger RNA, or mRNA, an infamously fragile molecule. In fact, we would not have mRNA COVID-19 vaccines today without a lesser-known technology: lipid nanoparticles, or LNPs, the delivery vehicles that shuttle these molecules into our cells.

Learn more about mRNA at Pfizer.com

While Pfizer is currently focused on developing mRNA vaccines to help prevent the flu and shingles and to treat rare diseases, it continues to explore other opportunities where the technology could make a transformational impact on patients, and where its expertise has the potential to accelerate the pace of innovation.

Learn more about mRNA at Pfizer.com.

With its proven success in vaccinations during the global pandemic, messenger ribonucleic acid, or mRNA, technology has hit prime time. The versatile platform is already being used to develop investigational vaccines against other infectious diseases. But its potential doesn’t end there. Over the next decade, this technology could transform medicine.

Learn more about mRNA at Pfizer.com

With its proven success in vaccinations during the global pandemic, messenger ribonucleic acid, or mRNA, technology has hit prime time. The versatile platform is already being used to develop investigational vaccines against other infectious diseases. But its potential doesn’t end there. Over the next decade, this technology could transform medicine.

Learn more about mRNA at Pfizer.com

In the past few decades, science has opened up new possibilities for maternal immunization. Join us this season to dive deeper into this topic: the history, challenges, innovations, and exciting developments to come.

Subscribe and listen to The Antigen wherever you get your podcasts

In the past few decades, science has opened up new possibilities for maternal immunization. Join us this season to dive deeper into this topic: the history, challenges, innovations, and exciting developments to come.

Subscribe and listen to The Antigen wherever you get your podcasts

Latest